Krystal Biotech: A Promising Gene Therapy Innovator

ImmunityBio: Amidst Difficulty Is Your Opportunity

Axsome: Promising Early Launch

ImmunoGen: Making A Successful Comeback

Avidity Biosciences: An Interesting Diversification

Ascendis Pharma: A Promising Diversification Play

Seres Therapeutics: Binary Catalyst Unlocking

Viking Therapeutics: A Promising NASH Diversification Play

89Bio: A Promising NASH Innovator

Axsome Therapeutics: SYMPHONY Catalyst Unlocking

Reata Pharmaceuticals: The Silver Bullet For Friedreich's Ataxia

G1 Therapeutics: Unexpected Setbacks Yet Value Remains

Ocular Therapeutix: A Promising Turnaround Play

Travere: Multiple Catalysts Stacking

Guardant Health: More Catalysts To Power Leaping Growth

NovoCure: Ramifications Of Recent Management Change

Iovance: Capturing A Lucrative Market

Intercept: Huge Potential Upsides With Binary Catalyst Unlocking

Reata Pharmaceuticals: Binary Catalyst Unlocking

DermTech: Momentum Rising With TRICARE

G1 Therapeutics: Poised For A Turnaround

Guardant Health: Positive ECLIPSE Data Signals More Upside

Voyager: Recent Neurocrine Deal Signals More Upside

Albireo Pharma: Elucidating The Ipsen Buyout (Rating Upgrade)

NovoCure: Catalysts Stacking For More Upside